Über uns
Über uns
Führungsteam
Unsere Verantwortung
Kollaborationen
Unsere Standorte
Technologie
Technologie
Produktion
Publikationen
Pipeline
Newsroom
News
Events
Downloads
Investor Relations
Überblick
Aktieninformation
Analysten-Coverage
Hauptversammlung
Finanzberichte
Corporate Governance
E-Mail Alert
Karriere
Werden Sie Teil der RNA people
Ausbildung
Aktuelle Stellenangebote
DE
Prophylactic Vaccines
A development, that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
by Sovereign
A novel, disruptive vaccination technology, Self-adjuvanted RNActive® vaccines
by Sovereign
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
by Sovereign
Developing mRNA-vaccine technologies
by Sovereign
1
2